Ticker

SARASOTA, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the fertility market, announced today that it will effect a 1-for-5 reverse split of its issued and outstanding and of its authorized common stock effective as of 12:01 a.m. Eastern Time on March 27, 2026. Commencing with the opening of trading on The Nasdaq Capital Market on March 27,…

INVO Fertility (NASDAQ: IVF - Get Free Report) and Revolutions Medical (OTCMKTS:RMCP - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings and risk. Risk and Volatility INVO Fertility has a beta

INVO Fertility, Inc (NASDAQ: IVF - Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 533,091 shares, a growth of 87.3% from the February 12th total of 284,595 shares. Based on an average trading volume of 1,337,849 shares,

SARASOTA, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced reproductive treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced the adoption of time-lapse incubation technology at its Wisconsin clinic.

INVO's Wisconsin Clinic is now in-network for Progyny members, expanding the clinic's market reach INVO's Wisconsin Clinic is now in-network for Progyny members, expanding the clinic's market reach